Skip to main content


Page 21 of 26

  1. Brain metastases are common in human epidermal growth factor receptor (Her)-2-positive breast cancer. Drug access to brain metastases and normal brain is key to management of cranial disease. In this study, po...

    Authors: Azeem Saleem, Graham E Searle, Laura M Kenny, Mickael Huiban, Kasia Kozlowski, Adam D Waldman, Laura Woodley, Carlo Palmieri, Charles Lowdell, Tomomi Kaneko, Philip S Murphy, Mike R Lau, Eric O Aboagye and Raoul C Coombes
    Citation: EJNMMI Research 2015 5:30

    The Erratum to this article has been published in EJNMMI Research 2017 7:74

    A Erratum has been published.

  2. J591 is a monoclonal antibody that targets the external domain of the prostate-specific membrane antigen (PSMA). Besides prostate cancer cells, it also targets the neovasculature of non-prostate solid tumors. ...

    Authors: Neeta Pandit-Taskar, Joseph A O’Donoghue, Chaitanya R Divgi, Eze A Wills, Lawrence Schwartz, Mithat Gönen, Peter Smith-Jones, Neil H Bander, Howard I Scher, Steven M Larson and Michael J Morris
    Citation: EJNMMI Research 2015 5:28
  3. The number of routine care patient examinations with 68Ga radiopharmaceuticals is still relatively limited, probably caused by the presumed need for large investments in hot cells, automated synthesis modules, la...

    Authors: Roeland Vis, Jules Lavalaye and Ewoudt MW van de Garde
    Citation: EJNMMI Research 2015 5:27
  4. Positron emission tomography (PET) with 18F-3′-deoxy-3′-fluorothymidine ([18F]FLT) can be used to assess tumour proliferation. A kinetic-filtering (KF) classification algorithm has been suggested for segmentation...

    Authors: Lieke L Hoyng, Virginie Frings, Otto S Hoekstra, Laura M Kenny, Eric O Aboagye and Ronald Boellaard
    Citation: EJNMMI Research 2015 5:26
  5. High-grade gliomas (HGGs) express somatostatin receptors (SSTR), rendering them candidates for peptide receptor radionuclide therapy (PRRT). Our purpose was to evaluate the potential of 68Ga-DOTA-1-Nal3-octreotid...

    Authors: Aida Kiviniemi, Maria Gardberg, Janek Frantzén, Marko Pesola, Ville Vuorinen, Riitta Parkkola, Tuula Tolvanen, Sami Suilamo, Jarkko Johansson, Pauliina Luoto, Jukka Kemppainen, Anne Roivainen and Heikki Minn
    Citation: EJNMMI Research 2015 5:25
  6. Features of the tumor microenvironment influence the efficacy of cancer nanotherapeutics. The ability to directly radiolabel nanotherapeutics offers a valuable translational tool to obtain biodistribution and ...

    Authors: Daniel F Gaddy, Helen Lee, Jinzi Zheng, David A Jaffray, Thomas J Wickham and Bart S Hendriks
    Citation: EJNMMI Research 2015 5:24
  7. [18F]Fludarabine is a novel positron emission tomography (PET) radiotracer for imaging lymphoma. The purpose of this preclinical study was to evaluate the robustness of [18F]fludarabine during rituximab therapy. ...

    Authors: Narinée Hovhannisyan, Stéphane Guillouet, Fabien Fillesoye, Martine Dhilly, Delphine Patin, Françoise Galateau, Michel Leporrier and Louisa Barré
    Citation: EJNMMI Research 2015 5:23
  8. Recently, an intra-patient comparison demonstrated that the somatostatin (sst) ligand [68Ga]HA-DOTATATE ([68Ga]DOTA-3-iodo-Tyr3-octreotate) provides PET images comparable to or superior to those obtained with [68

    Authors: Margret Schottelius, Jakub Šimeček, Frauke Hoffmann, Marina Willibald, Markus Schwaiger and Hans-Jürgen Wester
    Citation: EJNMMI Research 2015 5:22
  9. Tenascin-C (TNC), an extracellular matrix glycoprotein, is expressed transiently in distinct areas in association with active tissue remodeling. This study aimed to explore how ischemic postconditioning (PC) a...

    Authors: Junichi Taki, Anri Inaki, Hiroshi Wakabayashi, Ichiro Matsunari, Kyoko Imanaka-Yoshida, Kazuma Ogawa, Michiaki Hiroe, Kazuhiro Shiba, Toshimichi Yoshida and Seigo Kinuya
    Citation: EJNMMI Research 2015 5:21
  10. Over the last decade, an increasing number of studies have been published on the use of amyloid-β (Aβ) PET imaging with different 18F-radiopharmaceuticals for clinical characterization of Alzheimer’s disease (AD)...

    Authors: Behrooz H Yousefi, Boris von Reutern, Daniela Scherübl, André Manook, Markus Schwaiger, Timo Grimmer, Gjermund Henriksen, Stefan Förster, Alexander Drzezga and Hans-Jürgen Wester
    Citation: EJNMMI Research 2015 5:20
  11. With the recent growth of interest in cell-based therapies and radiolabeled cell products, there is a need to develop more robust cell labeling and imaging methods for in vivo tracking of living cells. This study...

    Authors: Aditya Bansal, Mukesh K Pandey, Yunus E Demirhan, Jonathan J Nesbitt, Ruben J Crespo-Diaz, Andre Terzic, Atta Behfar and Timothy R DeGrado
    Citation: EJNMMI Research 2015 5:19
  12. In vivo imaging using genetic reporters is a central supporting tool in the development of cell and gene therapies affording us the ability to selectively track the therapeutic indefinitely. Pr...

    Authors: Adam Badar, Louise Kiru, Tammy L Kalber, Amit Jathoul, Karin Straathof, Erik Årstad, Mark F Lythgoe and Martin Pule
    Citation: EJNMMI Research 2015 5:18
  13. The frequent expression of neurotensin receptors (NT-R) in primaries of pancreatic ductal carcinomas has triggered the development of radioactive neurotensin analogs for possible in vivo targeting of these tumors...

    Authors: Meike Körner, Beatrice Waser, Oliver Strobel, Markus Büchler and Jean Claude Reubi
    Citation: EJNMMI Research 2015 5:17
  14. The amount of inhomogeneities in a 99mTc Technegas single-photon emission computed tomography (SPECT) lung image, caused by reduced ventilation in lung regions affected by chronic obstructive pulmonary disease (C...

    Authors: Pernilla Norberg, Anna Olsson, Gudrun Alm Carlsson, Michael Sandborg and Agnetha Gustafsson
    Citation: EJNMMI Research 2015 5:16
  15. Deformable image registration allows volume of interest (VOI)- and voxel-based analysis of longitudinal changes in fluorodeoxyglucose (FDG) tumor uptake in patients with non-small cell lung cancer (NSCLC). Thi...

    Authors: Gerald SMA Kerner, Alexander Fischer, Michel JB Koole, Jan Pruim and Harry JM Groen
    Citation: EJNMMI Research 2015 5:15
  16. Tyrosine kinase inhibitors (TKIs) have experienced a tremendous boost in the last decade, where more than 15 small molecule TKIs have been approved by the FDA. Unfortunately, despite their promising clinical s...

    Authors: Paul Slobbe, Albert D Windhorst, Marijke Stigter-van Walsum, Egbert F Smit, Heiko G Niessen, Flavio Solca, Gerd Stehle, Guus A M S van Dongen and Alex J Poot
    Citation: EJNMMI Research 2015 5:14
  17. Management of infection is a major clinical problem. Staphylococcus aureus is a Gram-positive bacterium which colonises approximately one third of the adult human population. Staphylococcal infections can be life...

    Authors: Bethany Mills, Ramla O Awais, Jeni Luckett, Dave Turton, Paul Williams, Alan C Perkins and Philip J Hill
    Citation: EJNMMI Research 2015 5:13
  18. In specialized movement disorder centers, Parkinson’s disease (PD) is wrongly diagnosed in 6 to 25% of cases. To improve the accuracy of the clinical diagnosis, it is necessary to have a reliable and practical...

    Authors: Sven R Suwijn, Caroline JM van Boheemen, Rob J de Haan, Gerrit Tissingh, Jan Booij and Rob MA de Bie
    Citation: EJNMMI Research 2015 5:12
  19. Technetium-99m methoxyisobutylisonitrile (Tc MIBI) is a substrate with the same uptake kinetics as doxorubicin. Multidrug resistance (MDR) is a mechanism that impedes chemotherapy of non-small cell lung cancer...

    Authors: Shohei Kanno, Keita Utsunomiya, Yumiko Kono, Noboru Tanigawa and Satoshi Sawada
    Citation: EJNMMI Research 2015 5:11
  20. The purpose of this study was to quantitatively evaluate the tumor accumulation and heterogeneity of 111In-ibritumomab tiuxetan (Zevalin®) and tumor accumulation of 18F-fluoro-deoxyglucose (FDG) and compare them ...

    Authors: Kohei Hanaoka, Makoto Hosono, Yoichi Tatsumi, Kazunari Ishii, Sung-Woon Im, Norio Tsuchiya, Kenta Sakaguchi and Itaru Matsumura
    Citation: EJNMMI Research 2015 5:10
  21. Recent research has demonstrated the potential of 18-kDa translocator protein (TSPO) to serve as a target for nuclear imaging of gliomas. The aim of this study was to evaluate SPECT imaging of GL26 mouse gliom...

    Authors: Stergios Tsartsalis, Noé Dumas, Benjamin B Tournier, Tien Pham, Marcelle Moulin-Sallanon, Marie-Claude Grégoire, Yves Charnay and Philippe Millet
    Citation: EJNMMI Research 2015 5:9
  22. The purpose of this study was to determine whether brain metastases from HER2-positive breast cancer could be detected noninvasively using positron emission tomography (PET) with 64Cu-1,4,7,10-tetraazacyclododeca...

    Authors: Hiroaki Kurihara, Akinobu Hamada, Masayuki Yoshida, Schuichi Shimma, Jun Hashimoto, Kan Yonemori, Hitomi Tani, Yasuji Miyakita, Yousuke Kanayama, Yasuhiro Wada, Makoto Kodaira, Mayu Yunokawa, Harukaze Yamamoto, Chikako Shimizu, Kazuhiro Takahashi, Yasuyoshi Watanabe…
    Citation: EJNMMI Research 2015 5:8
  23. 3′-deoxy-3′-[18F]fluorothymidine (18F-FLT) has been used to evaluate tumor malignancy and cell proliferation in human brain gliomas. However, 18F-FLT has several limitations in clinical use. Recently, 11C-labeled...

    Authors: Yasunori Toyota, Keisuke Miyake, Nobuyuki Kawai, Tetsuhiro Hatakeyama, Yuka Yamamoto, Jun Toyohara, Yoshihiro Nishiyama and Takashi Tamiya
    Citation: EJNMMI Research 2015 5:7
  24. Systematic evaluations of the diagnostic accuracy of positron emission tomography (PET) imaging have been widely conducted in many countries. Although Japan’s total number of PET units is the second highest in...

    Authors: Shuhei Nomura, Akinori Hisashige, Daisuke Yoneoka, Mikiko Kanda, Karin Miyamoto, Miwako Segawa, Erika Ota and Kenji Shibuya
    Citation: EJNMMI Research 2015 5:6
  25. Botulinum neurotoxin A (BoNT-A) is a highly neurotoxic drug and frequently used in patients. Knowledge on the optimal way of administration of BoNT-A and its subsequent distribution is still rather limited. An...

    Authors: Janneke IM van Uhm, Gerard WM Visser, Marcel J van der Schans, Albert A Geldof, Eric JH Meuleman and Jakko A Nieuwenhuijzen
    Citation: EJNMMI Research 2015 5:5

    The Erratum to this article has been published in EJNMMI Research 2016 6:8

  26. Non-small cell lung carcinoma (NSCLC) represents approximately 80% of lung cancer cases, and over 60% of these tumors express the epidermal growth factor receptor (EGFR). Activating mutations in the tyrosine k...

    Authors: Galith Abourbeh, Batel Itamar, Olga Salnikov, Sergey Beltsov and Eyal Mishani
    Citation: EJNMMI Research 2015 5:4
  27. CD8-positive cells might play a crucial role in the therapeutic response to radiation, which has however not been investigated in radioimmunotherapy (RIT). The aim of this study was to evaluate whether cytotox...

    Authors: Erika Elgström, Sophie E Eriksson, Tomas G Ohlsson, Rune Nilsson and Jan Tennvall
    Citation: EJNMMI Research 2015 5:3
  28. CD13 is selectively upregulated in angiogenic active endothelium and can serve as a target for molecular imaging tracers to non-invasively visualise angiogenesis in vivo. Non-invasive determination of CD13 expres...

    Authors: Geert Hendrikx, Marijke De Saint-Hubert, Ingrid Dijkgraaf, Matthias Bauwens, Kim Douma, Roel Wierts, Ivo Pooters, Nynke MS Van den Akker, Tilman M Hackeng, Mark J Post and Felix M Mottaghy
    Citation: EJNMMI Research 2015 5:2
  29. In cancer radiotherapy, knowledge of normal tissue responses and toxicity risks is essential in order to deliver the highest possible absorbed dose to the tumor while maintaining normal tissue exposure at non-...

    Authors: Britta Langen, Nils Rudqvist, Toshima Z Parris, Emil Schüler, Johan Spetz, Khalil Helou and Eva Forssell-Aronsson
    Citation: EJNMMI Research 2015 5:1
  30. The goal of the present study was to evaluate the reproducibility of cerebral adenosine A2A receptor (A2AR) quantification using 11C-TMSX and PET in a test-retest study.

    Authors: Mika Naganawa, Masahiro Mishina, Muneyuki Sakata, Keiichi Oda, Mikio Hiura, Kenji Ishii and Kiichi Ishiwata
    Citation: EJNMMI Research 2014 4:76
  31. [18 F]AFM is a potent and promising PET imaging agent for the serotonin transporter. We carried out an acute toxicity study in rats and radiation dosimetry in monkeys before the translation of the tracer to human...

    Authors: Ya-Yao Huang, Chen-Yi Cheng, Wen-Sheng Huang, Kuo-Hsing Ma, Ta-Wei Tseng, Ta-Kai Chou, Yiyun Huang and Chyng-Yann Shiue
    Citation: EJNMMI Research 2014 4:71

    The Erratum to this article has been published in EJNMMI Research 2016 6:66

  32. Peptide receptor radionuclide therapy (PRRT) is applied in patients with advanced neuroendocrine tumors. Co-infused amino acids (AA) should prevent nephrotoxicity. The aims of this study were to correlate the ...

    Authors: Constantin Lapa, Rudolf A Werner, Christina Bluemel, Katharina Lueckerath, Dirk O Muegge, Alexander Strate, Heribert Haenscheid, Andreas Schirbel, Martin S Allen-Auerbach, Ralph A Bundschuh, Andreas K Buck and Ken Herrmann
    Citation: EJNMMI Research 2014 4:74
  33. Boron neutron capture therapy (BNCT) is a molecular radiation treatment based on the 10B (n, α) 7Li nuclear reaction in cancer cells, in which delivery of 10B by 4-borono-phenylalanine conjugated with fructose (B...

    Authors: Kohei Hanaoka, Tadashi Watabe, Sadahiro Naka, Yasukazu Kanai, Hayato Ikeda, Genki Horitsugi, Hiroki Kato, Kayako Isohashi, Eku Shimosegawa and Jun Hatazawa
    Citation: EJNMMI Research 2014 4:70
  34. Hepatobiliary scintigraphy using 99mTc-mebrofenin has been used as an investigation to study liver function after liver transplantation (LTx). Hepatic extraction fraction (HEF) is a measurement of the hepatic ext...

    Authors: Anastasios Kaxiras, Shinji Yamamoto, Gunnar Söderdahl, Annika Wernerson, Rimma Axelsson and Bo-Göran Ericzon
    Citation: EJNMMI Research 2014 4:73
  35. Endothelial dysfunction is associated with vascular risk factors such as dyslipidemia, hypertension, and diabetes, leading to coronary atherosclerosis. Sympathetic stress using cold-pressor testing (CPT) has b...

    Authors: Etienne Croteau, Jennifer M Renaud, Christine Archer, Ran Klein, Jean N DaSilva, Terrence D Ruddy, Rob SB Beanlands and Robert A deKemp
    Citation: EJNMMI Research 2014 4:68
  36. Absolute quantitative single-photon emission computed tomography (SPECT) has several important applications including monitoring tumor response after treatment and dose estimation for targeted radionuclide the...

    Authors: Nadège Anizan, Hao Wang, Xian C Zhou, Robert F Hobbs, Richard L Wahl and Eric C Frey
    Citation: EJNMMI Research 2014 4:67
  37. Tumor hypoxia is linked to invasion and metastasis but whether this associates with tumor growth rate is not well understood. We aimed to study the relationship between hypoxia evaluated with the positron emis...

    Authors: Antti Silvoniemi, Jonna Silén, Sarita Forsback, Eliisa Löyttyniemi, Aleksi R Schrey, Olof Solin, Reidar Grénman, Heikki Minn and Tove J Grönroos
    Citation: EJNMMI Research 2014 4:65
  38. Galectin-3 is a ß-galactoside-binding lectin expressed in most of tissues in normal conditions and overexpressed in myocardium from early stages of heart failure (HF). It is an established biomarker associated...

    Authors: Teresa Arias, Artiom Petrov, Jiqiu Chen, Hans de Haas, Carlos Pérez-Medina, Gustav J Strijkers, Roger J Hajjar, Zahi A Fayad, Valentín Fuster and Jagat Narula
    Citation: EJNMMI Research 2014 4:75
  39. At fluorodeoxyglucose/positron emission tomography (FDG/PET) examinations, a generally increased uptake of the skeletal muscles is sometimes encountered. As the tracer distribution constitutes a ‘zero-sum-game...

    Authors: Henry Lindholm, Fredrik Brolin, Cathrine Jonsson and Hans Jacobsson
    Citation: EJNMMI Research 2014 4:72
  40. Defining tumour volume for treatment response and radiotherapy planning is challenging and prone to inter- and intra-observer variability. Various automated tumour delineation methods have been proposed in the...

    Authors: Azadeh Firouzian, Matthew D Kelly and Jérôme M Declerck
    Citation: EJNMMI Research 2014 4:69
  41. The ability to quantify the capacity of a central nervous system (CNS) drug to cross the human blood-brain barrier (BBB) provides valuable information for de-risking drug development of new molecules. Here, we...

    Authors: Khanum Ridler, Vincent Cunningham, Mickael Huiban, Laurent Martarello, Sabina Pampols-Maso, Jan Passchier, Roger N Gunn, Graham Searle, Anissa Abi-Dargham, Mark Slifstein, Jeanette Watson, Marc Laruelle and Eugenii A Rabiner
    Citation: EJNMMI Research 2014 4:66
  42. We have explored the possibility that the serotonin 1B receptor radioligand [11C]AZ10419369 is a substrate for adenosine triphosphate (ATP)-binding cassette (ABC) transporters, such as P-glycoprotein (P-gp), Mrp4...

    Authors: Miklós Tóth, Jenny Häggkvist, Andrea Varrone, Sjoerd J Finnema, Janine Doorduin, Masaki Tokunaga, Makoto Higuchi, Balázs Gulyás and Christer Halldin
    Citation: EJNMMI Research 2014 4:64
  43. The serotonin precursor 5-hydroxy-l-[β-11C]tryptophan ([11C]HTP) is in clinical use for localization of neuroendocrine tumors and has been suggested as a proxy marker for pancreatic islet cells. However, degradat...

    Authors: Jonas Eriksson, Ola Åberg, Ram Kumar Selvaraju, Gunnar Antoni, Lars Johansson and Olof Eriksson
    Citation: EJNMMI Research 2014 4:62
  44. Due to its high expression in prostate cancer, PSMA (prostate-specific membrane antigen) represents an ideal target for both diagnostic imaging and endoradiotherapeutic approaches. Based on a previously publis...

    Authors: Martina Weineisen, Jakub Simecek, Margret Schottelius, Markus Schwaiger and Hans-Jürgen Wester
    Citation: EJNMMI Research 2014 4:63
  45. Three-dimensional (3D) hydrogel-based stem cell therapies contribute to enhanced therapeutic efficacy in treating diseases, and determining the optimal mechanical strength of the hydrogel in vivo is important for...

    Authors: Do Won Hwang, Kyung Min Park, Hye-kyung Shim, Yeona Jin, Hyun Jeong Oh, So Won Oh, Song Lee, Hyewon Youn, Yoon Ki Joung, Hong J Lee, Seung U Kim, Ki Dong Park and Dong Soo Lee
    Citation: EJNMMI Research 2014 4:61
  46. Epithelial ovarian cancer (EOC) is characterized by the overexpression of cancer antigen 125 (CA125), a mucinous glycoprotein that serves as a tumor biomarker. Early diagnosis of EOC is plagued by its asymptom...

    Authors: Sai Kiran Sharma, Melinda Wuest, Monica Wang, Darryl Glubrecht, Bonnie Andrais, Suzanne E Lapi and Frank Wuest
    Citation: EJNMMI Research 2014 4:60
  47. The kidneys are regarded as one of the main dose-limiting organs in the treatment of neuroendocrine tumours with 177Lu-[DOTA0, Tyr3]-octreotate (177Lu-octreotate), despite the successful use of kidney uptake bloc...

    Authors: Johanna Dalmo, Emelie Westberg, Lars Barregard, Lisa Svedbom, Martin Johansson, Margareta Törnqvist and Eva Forssell-Aronsson
    Citation: EJNMMI Research 2014 4:59
  48. Bone Scan Index (BSI) is a quantitative measurement of tumour burden in the skeleton calculated from bone scan images. When analysed at the time of diagnosis,it has been shown to provide prognostic information...

    Authors: Mariana Reza, Anders Bjartell, Mattias Ohlsson, Reza Kaboteh, Per Wollmer, Lars Edenbrandt and Elin Trägårdh
    Citation: EJNMMI Research 2014 4:58
  49. In vivo bioluminescence, fluorescence, and single-photon emission computed tomography (SPECT) imaging provide complementary information about biological processes. However, to date these signatures are evaluated ...

    Authors: Matthias N van Oosterom, Rob Kreuger, Tessa Buckle, Wendy A Mahn, Anton Bunschoten, Lee Josephson, Fijs WB van Leeuwen and Freek J Beekman
    Citation: EJNMMI Research 2014 4:56
  50. Hepatic mitochondrial dysfunction has been implicated in pathological conditions leading to non-alcoholic steatohepatitis (NASH). Technetium-99 m-2-methoxyisobutyl-isonitrile (99mTc-MIBI), a lipophilic cationic m...

    Authors: Takemi Rokugawa, Tomoya Uehara, Yusuke Higaki, Shuuichi Matsushima, Atsushi Obata, Yasushi Arano and Kohji Abe
    Citation: EJNMMI Research 2014 4:57

EANM'24 - Future Congress!

EANM'24 banner horizontal

Future Congress

37th Annual Congress of the European Association of Nuclear Medicine

October 19 – 23, 2024
Hamburg, Germany

CCH – Congress Center Hamburg
Congressplatz 1
20355 Hamburg, Germany

The EJNMMI Journal Family and EANM Springer Award

New Content Item

EJNMMI is part of the EJNMMI Journal Family. Highlights of our featured content and the latest developments from the EJNMMI group of journals can be found on the EJNMMI Journal Family webpage. There you find details about the annual EANM Springer Prize.

Do you want to publish your paper open access?

Details of the OpenChoice option in EJNMMI are available in the submission guidelines.

If your institution has a Read and Publish (Springer Compact) agreement, you may publish your article open access at no cost to you. In addition, you can enjoy full access to all Springer subscription journal content.

Please check the agreement details by participating country here.